Lombard Odier Asset Management USA Corp Has $2.90 Million Position in McKesson Corporation $MCK

Lombard Odier Asset Management USA Corp grew its stake in McKesson Corporation (NYSE:MCK) by 21.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,751 shares of the company’s stock after acquiring an additional 674 shares during the quarter. Lombard Odier Asset Management USA Corp’s holdings in McKesson were worth $2,898,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Vanguard Group Inc. grew its holdings in McKesson by 2.0% during the second quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company’s stock valued at $8,846,186,000 after purchasing an additional 232,286 shares during the period. Franklin Resources Inc. increased its stake in McKesson by 3.5% in the third quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company’s stock valued at $2,071,428,000 after purchasing an additional 90,948 shares in the last quarter. Alliancebernstein L.P. raised its holdings in McKesson by 5.6% in the third quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company’s stock worth $1,850,001,000 after purchasing an additional 126,684 shares during the period. Norges Bank bought a new position in shares of McKesson during the second quarter worth $1,346,661,000. Finally, Boston Partners boosted its position in shares of McKesson by 6.7% during the third quarter. Boston Partners now owns 1,330,953 shares of the company’s stock worth $1,027,569,000 after purchasing an additional 83,357 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Maria Martinez sold 349 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the sale, the director owned 301 shares in the company, valued at $282,900.87. The trade was a 53.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,868 shares of company stock worth $3,743,820 over the last three months. Company insiders own 0.08% of the company’s stock.

McKesson Stock Up 0.3%

Shares of MCK stock opened at $943.43 on Tuesday. The company’s fifty day simple moving average is $896.29 and its 200-day simple moving average is $828.19. The firm has a market cap of $115.56 billion, a PE ratio of 27.13, a P/E/G ratio of 1.51 and a beta of 0.38. McKesson Corporation has a 12 month low of $637.00 and a 12 month high of $999.00.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter in the prior year, the company posted $8.03 earnings per share. The firm’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts predict that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. Morgan Stanley restated an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research report on Thursday, January 29th. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings cut McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. JPMorgan Chase & Co. increased their target price on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, McKesson has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.